Document is current
Any future updates will be listed below
-
Authors
Shin, Mirim https://orcid.org/0000-0002-1648-341X
Crouse, Jacob J. https://orcid.org/0000-0002-3805-2936
Weger, Meltem
McKenna, Sarah https://orcid.org/0000-0002-8560-6399
Wray, Naomi R. https://orcid.org/0000-0001-7421-3357
Scott, Elizabeth M.
Hickie, Ian B. https://orcid.org/0000-0001-8832-9895
Gachon, Frédéric https://orcid.org/0000-0002-9279-9707
-
Funding
Funding for this research was provided by:
This work was supported by a philanthropic donation to MS from families affected by mental illness, who would like to remain anonymous
Department of Health | National Health and Medical Research Council (2008196, 2019260, 1173790, 2019260, 2016346, 2019260, 2019260)
Novo Nordisk Fonden (0087882)
- License Information
-
More Information
Article History
First Online: 13 August 2025
Competing interests
: I.B.H. is co-director, health and policy, at the Brain and Mind Centre, University of Sydney, Australia, which operates an early-intervention youth services at Camperdown under contract to headspace. He has previously led community-based projects and pharmaceutical industry–supported projects (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca and Janssen Cilag) focused on the identification and better management of anxiety and depression. He is the chief scientific advisor to and is a 3.2% equity shareholder in InnoWell, which aims to transform mental health services through the use of innovative technologies.
